These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17951401)

  • 1. Osteoactivin promotes breast cancer metastasis to bone.
    Rose AA; Pepin F; Russo C; Abou Khalil JE; Hallett M; Siegel PM
    Mol Cancer Res; 2007 Oct; 5(10):1001-14. PubMed ID: 17951401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
    Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
    Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
    Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL
    Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
    Manka D; Spicer Z; Millhorn DE
    Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
    Sung V; Gilles C; Murray A; Clarke R; Aaron AD; Azumi N; Thompson EW
    Exp Cell Res; 1998 Jun; 241(2):273-84. PubMed ID: 9637769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
    Rose AA; Grosset AA; Dong Z; Russo C; Macdonald PA; Bertos NR; St-Pierre Y; Simantov R; Hallett M; Park M; Gaboury L; Siegel PM
    Clin Cancer Res; 2010 Apr; 16(7):2147-56. PubMed ID: 20215530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S; Jiang WG
    Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
    España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
    Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin.
    Fradet A; Sorel H; Bouazza L; Goehrig D; Dépalle B; Bellahcène A; Castronovo V; Follet H; Descotes F; Aubin JE; Clézardin P; Bonnelye E
    Cancer Res; 2011 Sep; 71(17):5728-38. PubMed ID: 21734015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
    Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro.
    Bucciarelli E; Sidoni A; Bellezza G; Cavaliere A; Brachelente G; Costa G; Chaplet M; Castronovo V; Bellahcène A
    Breast Cancer Res Treat; 2007 Sep; 105(1):95-104. PubMed ID: 17136477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
    Xia TS; Wang GZ; Ding Q; Liu XA; Zhou WB; Zhang YF; Zha XM; Du Q; Ni XJ; Wang J; Miao SY; Wang S
    Breast Cancer Res Treat; 2012 Apr; 132(2):471-86. PubMed ID: 21638054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer-derived factors facilitate osteolytic bone metastasis.
    Rose AA; Siegel PM
    Bull Cancer; 2006 Sep; 93(9):931-43. PubMed ID: 16980236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.